Reiter's syndrome following intravesical BCG immunotherapy.
A 71 year old woman developed conjunctivitis, asymmetrical oligoarthritis, and cystitis (Reiter's syndrome) secondary to intravesical BCG treatment for transitional cell carcinoma of the bladder. She received oral prednisolone, izoniazid, and pyridoxine and made a full recovery. Increasing use of BCG as immunotherapy will lead to an increase in the incidence of BCG associated reactive arthritis. Prompt recognition and early diagnosis will facilitate treatment and recovery.
Hogarth
M B
MB
Department of Rheumatology, St Mary's Hospital, Praed Street, London W2 1NY, UK.
Thomas
S
S
Seifert
M H
MH
Tariq
S M
SM
D000368:Aged; D016918:Arthritis, Reactive / Q000209:etiology*; D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000628:therapy; D005260:Female; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000628:therapy
D001500:BCG Vaccine